Marathon Pharmaceuticals, LLC Launches Zingo® (Lidocaine Hydrochloride Monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic To Manage Venous Access Pain

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals, LLC today announced the availability of ZiNGO® (lidocaine hydrochloride monohydrate, 0.5 mg) powder intradermal injection system, a needle-free, easy to use device to deliver a topical local anesthetic to manage venous access pain in as little as one to three minutes.

ZiNGO® is a hand-held device that, with the push of a button, delivers a 0.5 mg dose of powdered lidocaine particles into the skin via a helium-powered delivery system, numbing the site in one to three minutes. This rapid onset means the product can be incorporated into a medical procedure requiring venous access, allowing uninterrupted care. ZiNGO® is sterile, for single-use and does not need to be refrigerated.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC